ABSTRACT
With the introduction of endoscopic retrograde cholangiopancreatography and linear endoscopic ultrasound, interventional pancreaticobiliary (PB) endoscopy has had an enormous impact in the management of pancreatic and biliary diseases. Continuous efforts to improve various devices and techniques have revolutionized these treatment modalities as viable alternatives to surgery. In recent years, trends toward combining endoscopic techniques with other modalities, such as laparoscopic and radiological interventions, for complex PB diseases have emerged using a multidisciplinary approach. Ongoing research and clinical experience will lead to refinements in interventional PB endoscopic techniques and subsequently improve outcomes and reduce complication rates.
Subject(s)
Biliary Tract Diseases , Cholangiopancreatography, Endoscopic Retrograde , Endosonography , Pancreatic Diseases , Humans , Cholangiopancreatography, Endoscopic Retrograde/methods , Pancreatic Diseases/surgery , Pancreatic Diseases/diagnostic imaging , Biliary Tract Diseases/surgery , Biliary Tract Diseases/diagnostic imaging , Endosonography/methods , History, 20th Century , History, 21st Century , Endoscopy, Digestive System/methods , Endoscopy, Digestive System/instrumentationSubject(s)
Pancreatic Diseases , Humans , Pancreatic Diseases/diagnostic imaging , Endoscopy, Digestive System/methods , Endoscopy, Digestive System/instrumentation , Cholangiopancreatography, Endoscopic Retrograde/methods , Biliary Tract Diseases/diagnostic imaging , Biliary Tract Diseases/diagnosisABSTRACT
Endoscopic ultrasonography (EUS) provides high spatial resolution and more detailed images than other diagnostic modalities. Furthermore, EUS-guided tissue acquisition (EUS-TA), such as EUS-guided fine needle aspiration or biopsy (EUS-FNA/FNB), is an indispensable tool in pancreaticobiliary disease diagnostics, supporting a conclusive pathological diagnosis. In this review, we evaluate the current status and the usefulness of EUS-TA for the diagnostics of the following biliary tract diseases: (A) biliary stricture diagnostics, (B) biliary tract cancer (BTC) itself, and (C) staging of advanced BTC. Previous reports have shown that EUS-FNA for biliary lesions is a safe procedure that is useful in differentiating biliary cancer from benign lesions and in the staging of BTC. On the other hand, the diagnostic performance of EUS-TA for bile duct lesions is reported to be similar to that of transpapillary biopsy. Overall, EUS-TA for biliary lesions may be a safe and effective method, but it should be performed with an understanding of the risk of serious adverse events such as bile leakage and peritoneal dissemination of cancer. It is recommended for distal biliary stricture lesions for which endoscopic retrograde cholangiopancreatography cannot confirm the diagnosis or gallbladder lesions if they do not require the needle to pass through the biliary lumen.
Subject(s)
Endoscopic Ultrasound-Guided Fine Needle Aspiration , Humans , Endoscopic Ultrasound-Guided Fine Needle Aspiration/methods , Endosonography/methods , Constriction, Pathologic/diagnostic imaging , Gallbladder Neoplasms/diagnostic imaging , Gallbladder Neoplasms/pathology , Gallbladder/diagnostic imaging , Gallbladder/pathology , Biliary Tract Diseases/diagnostic imaging , Biliary Tract Neoplasms/diagnostic imaging , Biliary Tract Neoplasms/pathologyABSTRACT
The progress of endoscopic diagnosis and treatment for inflammatory diseases of the biliary tract and pancreas have been remarkable. Endoscopic ultrasonography (EUS) and EUS-elastography are used for the diagnosis of early chronic pancreatitis and evaluation of endocrine and exocrine function in chronic pancreatitis. Notably, extracorporeal shock wave lithotripsy and electrohydraulic shock wave lithotripsy have improved the endoscopic stone removal rate in patients for whom pancreatic stone removal is difficult. Studies have reported the use of self-expanding metal stents for stent placement for pancreatic duct stenosis and EUS-guided pancreatic drainage for refractory pancreatic duct strictures. Furthermore, EUS-guided drainage using a double-pigtailed plastic stent has been performed for the management of symptomatic pancreatic fluid collection after acute pancreatitis. Recently, lumen-apposing metal stents have led to advances in the treatment of walled-off necrosis after acute pancreatitis. EUS-guided biliary drainage is an alternative to refractory endoscopic biliary drainage and percutaneous transhepatic biliary drainage for the treatment of acute cholangitis. The placement of an inside stent followed by switching to uncovered self-expanding metal stents in difficult-to-treat cases has been proposed for acute cholangitis by malignant biliary obstruction. Endoscopic transpapillary gallbladder drainage is an alternative to percutaneous transhepatic gallbladder drainage for severe and some cases of moderate acute cholecystitis. EUS-guided gallbladder drainage has been reported as an alternative to percutaneous transhepatic gallbladder drainage and endoscopic transpapillary gallbladder drainage. However, it is important to understand the advantages and disadvantages of each drainage method and select the optimal drainage method for each case.
Subject(s)
Endosonography , Humans , Endosonography/methods , Biliary Tract Diseases/surgery , Biliary Tract Diseases/therapy , Biliary Tract Diseases/diagnostic imaging , Biliary Tract Diseases/diagnosis , Drainage/methods , Endoscopy, Digestive System/methods , Stents , Pancreatic Diseases/therapy , Pancreatic Diseases/diagnostic imaging , Pancreatic Diseases/surgery , Pancreatitis/therapyABSTRACT
Magnetic resonance cholangiopancreatography (MRCP) has become a widely accepted noninvasive diagnostic tool in the assessment of pancreatic and biliary disease. MRCP essentially exploits extended T2 relaxation times of slow-moving fluid and delineates the outline of biliary and pancreatic ducts on T2-weighted images. In order to maximize the clinical implication of MRCP, it is of utmost importance for radiologists to optimize the acquisition technique, be aware of patient-related factors and physiologic changes than can affect its performance and interpretation. It is critical to understand the most common artifacts and pitfalls encountered during acquisition and interpretation of MRCP. We provide a general overview of the different pitfalls encountered in MRCP and pearls on how to manage them in real-world practice.
Subject(s)
Bile Duct Diseases , Biliary Tract Diseases , Pancreatic Diseases , Humans , Cholangiopancreatography, Magnetic Resonance/methods , Pancreatic Diseases/diagnostic imaging , Biliary Tract Diseases/diagnostic imaging , Pancreatic Ducts/diagnostic imaging , Pancreatic Ducts/pathology , Magnetic Resonance Imaging/methodsABSTRACT
Pathologies of the biliary tree include a wide-spectrum of benign and malignant processes. The differential for benign disease includes congenital and acquired disease with variable prognosis and management pathways. Given the ability to mimic malignancy, benign processes are difficult to diagnose by imaging. Direct cholangiography techniques with tissue sampling are the gold standards for the diagnosis of benign and malignant biliary pathologies. Non-invasive imaging with ultrasound offers a first-line diagnostic tool while MRI/MRCP offers higher specificity for identifying underlying pathology and distinguishing from malignant disease. In this review, we focus on the imaging appearance of dilatation, cystic anomalies obstruction, inflammation, ischemia, strictures, pneumobilia, and hemobilia to help construct a differential for benign processes.
Subject(s)
Biliary Tract Diseases , Biliary Tract , Humans , Cholangiopancreatography, Endoscopic Retrograde/methods , Cholangiography/methods , Magnetic Resonance Imaging/methods , Ultrasonography , Sensitivity and Specificity , Biliary Tract Diseases/diagnostic imagingABSTRACT
This article presents the MR protocols, imaging features, diagnostic criteria, and complications of commonly encountered emergencies in pancreaticobiliary imaging, which include pancreatic trauma, bile leak, acute cholecystitis, biliary obstruction, and pancreatitis. Various classifications and complications that can arise with these conditions, as well as artifacts that may mimic pathology, are also included. Finally, the emerging utility of abbreviated MR protocols is discussed.
Subject(s)
Biliary Tract Diseases , Pancreatic Diseases , Pancreatitis , Biliary Tract Diseases/diagnostic imaging , Emergencies , Humans , Magnetic Resonance Imaging/methods , Pancreatic Diseases/diagnostic imaging , Pancreatitis/diagnostic imagingABSTRACT
BACKGROUND/PURPOSE: Compared with currently available duodenoscopy-assisted systems, direct peroral cholangioscopy (DPOC) using an ultra-slim endoscope is limited by technical difficulties. The multibending (MB) ultra-slim endoscope was introduced as a dedicated cholangioscope for DPOC to challenge the technical problem. We retrospectively analyzed the clinical utility of DPOC using an MB endoscope with free-hand insertion into the bile duct in patients with biliary diseases. METHODS: A total of 145 patients who underwent DPOC using an MB endoscope were analyzed. The primary outcome was the technical success rate of DPOC using the free-hand insertion of the MB endoscope. The secondary outcomes were the technical success rates of DPOC-guided diagnostic and therapeutic interventions, the diagnostic accuracy of DPOC-guided target biopsy, and adverse events related to DPOC. RESULTS: Free-hand biliary insertion of a MB endoscope for DPOC was technically successful in 133 patients (91.7%). DPOC-guided target biopsy was successful in 36 of 38 patients (94.7%) and had a diagnostic accuracy of 91.7% (95% confidence interval, 82.6-100). Sixty-nine therapeutic interventions were performed; technical success was achieved in 65 (94.2%). No severe adverse events were observed. CONCLUSIONS: The MB ultra-slim endoscope was technically effective to perform a DPOC including various diagnosis and therapeutic interventions without device assistance. MB endoscope is considered to contribute to expanding a role of DPOC in diagnosis and treatment of diverse biliary tract diseases.
Subject(s)
Biliary Tract Diseases , Gallbladder Diseases , Humans , Retrospective Studies , Endoscopy, Digestive System/adverse effects , Endoscopes , Biliary Tract Diseases/diagnostic imaging , Biliary Tract Diseases/surgery , Gallbladder Diseases/etiologySubject(s)
Biliary Tract Diseases , Biliary Tract , Liver Transplantation , Biliary Tract Diseases/diagnostic imaging , Biliary Tract Diseases/etiology , Biliary Tract Diseases/surgery , Cholangiopancreatography, Endoscopic Retrograde , Humans , Liver Transplantation/adverse effects , Postoperative Complications/etiology , Postoperative Complications/therapy , Retrospective StudiesABSTRACT
ABSTRACT: Endoscopic retrograde cholangiopancreatography (ERCP) is the gold standard for minimally-invasive treatment of biliary or pancreatic tract disease. When treating patients on intensive care units (ICU) with ERCP, interventionalists are faced with considerably higher morbidity compared to patients in ambulatory settings. However, data on complications and outcome of critical ill patients undergoing emergency ERCP are limited.A retrospective analysis of 102 patients treated on ICUs undergoing 121 ERCP procedures at the University Hospital of Essen, Germany between 2002 and 2016 was performed. Indications, interventional success, outcome including survival and procedure-related complications were analyzed. Patients' condition pre-ERCP was categorized by using the "Simplified Acute Physiology Score" (SAPS 3).66/102 patients (64.7%) were referred to ERCP from surgical ICU, 36/102 (35.3%) from nonsurgical ICU. The majority of patients were male (63.7%), the mean age was 54.1â±â14.9 [21-88] years. Indications for ERCP were biliary complications after liver transplantation (nâ=â34, 33.3%), biliary leakage after hepatobiliary surgery (nâ=â32, 31.4%), and cholangitis/biliary sepsis (nâ=â36; 35.3%), respectively. 117/121 (96.7%) ERCPs were successful, 1 patient (1.0%) died during ERCP. Post-ERCP pancreatitis occurred in 11.8% of interventions. The median simplified acute physiology score 3 was 65 points, predicting a risk-adjusted estimated mortality of 48.8%, corresponding to an observed mortality of 52.2% (Pâ=ân.s.).ERCP is safe in critically ill patients on ICU, it does not increase overall mortality rate and has a relatively low rate of procedure-associated complications.
Subject(s)
Biliary Tract Diseases , Cholangiopancreatography, Endoscopic Retrograde , Pancreatitis , Adult , Aged , Aged, 80 and over , Biliary Tract Diseases/diagnostic imaging , Cholangiopancreatography, Endoscopic Retrograde/adverse effects , Critical Illness , Female , Humans , Male , Middle Aged , Pancreatitis/etiology , Retrospective Studies , Young AdultABSTRACT
The history of ascariasis is very old. It is endemic in various parts of Bangladesh. Hepatobiliary ascariasis is a well-known complication of the intestinal ascariasis. Although cosmopolitan, it predominantly affects people in Asia, Africa, and South America. This was a prospective observational study conducted from July to December 2014 to explore the short term outcome of therapeutic ERCP in the treatment of biliary ascariasis in a tertiary care hospital of Bangladesh. A total of 60 cases of biliary ascariasis were selected conveniently in this study. Data were collected by face-to-face interviews and observation with the help of data sheet. Data were checked for quality control and analyzed by computer using SPSS software. The mean±SD age of the patients was 30.96±7.66 years. All the patients were aged between 17 and 55 years and predominantly affect women in the 3rd and 4th decades. The most common presentation was upper abdominal pain in 47(83.32%) of the patients. Ultrasound was the diagnostic tool of choice, where biliary ascariasis was found in 40(66.7%) of patients. ERCP is reserved mainly for therapeutic purposes and found successful in 57(95%) of the patients.
Subject(s)
Ascariasis , Biliary Tract Diseases , Adolescent , Adult , Ascariasis/diagnostic imaging , Ascariasis/therapy , Bangladesh , Biliary Tract Diseases/diagnostic imaging , Biliary Tract Diseases/therapy , Cholangiopancreatography, Endoscopic Retrograde , Female , Humans , Middle Aged , Tertiary Care Centers , Young AdultABSTRACT
PURPOSE: To discern whether preceding ultrasound (US) results, patient demographics and biochemical markers can be implemented as predictors of an abnormal Magnetic Resonance Cholangiopancreatography (MRCP) study in the context of acute pancreaticobiliary disease. METHODS: A retrospective study was performed assessing US results, age, gender, elevated lipase and biliary enzymes for consecutive patients who underwent an urgent MRCP following an initial US for acute pancreaticobiliary disease between January 2017-December 2018. Multivariable binary logistic regression models were constructed to assess for predictors of clinically significant MRCPs, and discrepant US/MRCP results. RESULTS: A total of 155 patients (mean age 56, 111 females) were included. Age (OR 1.03, P < 0.05), hyperlipasemia (OR 5.33, P < 0.05) and a positive US (OR 40.75, P < 0.05) were found to be independent predictors for a subsequent abnormal MRCP. Contrarily, gender and elevated biliary enzymes were not reliable predictors of an abnormal MRCP, or significant MRCP/US discrepancies. Of 66 cases (43%) of discordant US/MRCPs, half had clinically significant discrepant findings such as newly discovered choledocholithiasis and pancreaticobiliary neoplasia. Age was the sole predictor for a significant US/MRCP discrepancy, with 2% increase in the odds of a significant discrepancy per year of increase in age. CONCLUSION: An abnormal US, hyperlipasemia and increased age serve as predictors for a subsequent abnormal MRCP, as opposed to gender and biliary enzyme elevation. Age was the sole predictor of a significant US/MRCP discrepancy that provided new information which significantly impacted subsequent management. In the remaining cases, however, MRCP proved useful in reaffirming the clinical diagnosis and avoiding further investigations.
Subject(s)
Biliary Tract Diseases/diagnostic imaging , Cholangiopancreatography, Magnetic Resonance/methods , Acute Disease , Adolescent , Adult , Aged , Aged, 80 and over , Bile Ducts/diagnostic imaging , Female , Humans , Male , Middle Aged , Pancreatic Ducts/diagnostic imaging , Reproducibility of Results , Retrospective Studies , Young AdultABSTRACT
Refractory bile leaks represent a damaging sequela of hepatobiliary surgery and direct trauma. Management of bile leaks represents a challenging clinical problem. Despite advances in endoscopic techniques, interventional radiology continues to play a vital role in the diagnosis and management of refractory bile leaks. This article reviews strategies for optimizing the diagnosis and management of bile leaks and provides an overview of management strategies, including the management of complicated biliary leaks.
Subject(s)
Biliary Tract Diseases , Cholangiopancreatography, Endoscopic Retrograde , Bile , Bile Ducts/diagnostic imaging , Bile Ducts/surgery , Biliary Tract Diseases/diagnostic imaging , Biliary Tract Diseases/surgery , Cholangiopancreatography, Endoscopic Retrograde/methods , Humans , Radiology, InterventionalSubject(s)
Biliary Tract Diseases/etiology , Cholecystectomy, Laparoscopic , Colic/etiology , Gallstones/diagnosis , Gallstones/surgery , Adult , Biliary Tract Diseases/diagnostic imaging , Colic/diagnostic imaging , Conservative Treatment , Diagnosis, Differential , Female , Gallstones/complications , Gallstones/diagnostic imaging , Hospitalization , Humans , Liver Function Tests , Primary Health Care , UltrasonographyABSTRACT
ABSTRACT: In this single-center retrospective study, we intended to evaluate the frequencies and characteristics of computed tomography findings of pancreatobiliary inflammation (PBI) in patients treated with lenvatinib and the relationship of these findings with treatment-planning changes.We included 78 patients (meanâ±âstandard deviation, 69.8â±â9.4âyears, range: 39-84âyears, 62 men) with hepatocellular carcinoma (nâ=â62) or thyroid carcinoma (nâ=â16) who received lenvatinib (June 2016-September 2020). Two radiologists interpreted the posttreatment computed tomography images and assessed the radiological findings of PBI (symptomatic pancreatitis, cholecystitis, or cholangitis). The PBI effect on treatment was statistically evaluated.PBI (pancreatitis, nâ=â1; cholecystitis, nâ=â7; and cholangitis, nâ=â2) was diagnosed in 11.5% (9/78) of the patients at a median of 35âdays after treatment initiation; 6 of 9 patients discontinued treatment because of PBI. Three cases of cholecystitis and 1 of cholangitis were accompanied by gallstones, while the other 5 were acalculous. The treatment duration was significantly shorter in patients with PBI than in those without (median: 44âdays vs. 201âdays, Pâ=â.02). Overall, 9 of 69 patients without PBI showed asymptomatic gallbladder subserosal edema.Lenvatinib-induced PBI developed in 11.5% of patients, leading to a significantly shorter treatment duration. Approximately 55.6% of the PBI cases were acalculous. The recognition of this phenomenon would aid physicians during treatment planning in the future.